30.05.2024 04:53:46 - dpa-AFX: Zimmer Biomet To Repurchase Up To $2 Bln Of Common Stock
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) said that its board
has approved a new stock repurchase authorization, granting the company
authority to repurchase up to $2 billion in common stock.
At 2024 Investor Day event, Zimmer Biomet provided its long-range plan for 2024
through 2027, including delivering Mid-single-digit percentage constant currency
consolidated revenue compound annual growth rate (CAGR); Adjusted earnings per
share growth at least 1.5 times revenue growth; Free Cash Flow growing at least
100 basis points faster than adjusted earnings per share.
Zimmer Biomet also announced that it has formalized a partnership with CBRE
Group Inc. (CBRE) to develop and outfit orthopedic ambulatory surgery centers in
the U.S.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX